Chemomab has gained a new EU patent for CM-101 covering its use in liver diseases including PSC, adding to the robust patent estate in major territories..
European Patent Office Grants New Patent Covering Use of CM-101 for the Treatment of Multiple Liver Diseases including Primary Sclerosing Cholangitis Further Extends Protections Afforded by.
Abstract Accepted for Oral Presentation at International Congress of Endocrinology (ICE 2022)Appointment of P.J. Ramtin as Senior Vice President of Business OperationsExpansion of Tildacerfont Patent Portfolio Estate with Key Method of Use PatentsSAN FRANCISCO (BUSINESS WIRE) Spruce Biosciences, Inc. (Nasdaq: SPRB.